The market shrugged off the nation’s carrier’s move to decrease domestic capacity and axe routes, but it may still pay the price for the ongoing spike in fuel costs.
Markets
Chief executive James Manning wants his company to complete the dual-listing this quarter. But the impending global roadshow may throw up some personal questions.
Analysts and investors are concerned PEXA’s core business earnings could become “significantly worse” as risks compound.
After more than 20 years developing its blood cancer immunotherapies, HaemaLogiX is preparing to kick off its IPO next week. Unless Trump’s Iran war gets in the way.
Even though both were criticised for selling down large amounts of stock earlier this year, their departure still spooked the market, wiping $500 million from Droneshield’s value.
